Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
The Lancet. Psychiatry
|
August 23, 2015
Improved identification of people at risk of psychosis: is it value for money?
Ben Kearns
Pharmacoeconomics
|
October 5, 2013
Aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar I disorder in children and adolescents: a NICE single technology appraisal
Lesley Uttley, Ben Kearns, Shijie Ren, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 6, 2022
Optimizing the Design of a Repeated Fecal Immunochemical Test Bowel Cancer Screening Programme With a Limited Endoscopy Capacity From a Health Economic Perspective
Sophie Whyte, Chloe Thomas, Jim Chilcott, et al.
Pharmacoeconomics
|
November 26, 2019
How Uncertain is the Survival Extrapolation? A Study of the Impact of Different Parametric Survival Models on Extrapolated Uncertainty About Hazard Functions, Lifetime Mean Survival and Cost Effectiveness
Ben Kearns, John Stevens, Shijie Ren, et al.
Pharmacoeconomics
|
April 13, 2013
Cabazitaxel for the second-line treatment of metastatic hormone-refractory prostate cancer: a NICE single technology appraisal
Ben Kearns, Myfanwy Lloyd Jones, Matt Stevenson, et al.
BMC Medicine
|
February 5, 2017
Erratum to: Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation
Ben Kearns, Jim Chilcott, Sophie Whyte, et al.
BMC Research Notes
|
July 9, 2014
Predicting preference-based utility values using partial proportional odds models
Roberta Ara, Ben Kearns, Ben A vanHout, et al.
BMC Medicine
|
December 7, 2016
Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation
Ben Kearns, Jim Chilcott, Sophie Whyte, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
June 20, 2023
A Systematic Review and Statistical Analysis of Factors Influencing the Cost-Effectiveness of Transcatheter Aortic Valve Implantation for Symptomatic Severe Aortic Stenosis
Laura Heathcote, Tushar Srivastava, Archita Sarmah, et al.
British Journal of Cancer
|
October 17, 2023
The cost-effectiveness of risk-stratified breast cancer screening in the UK
Harry Hill, Ben Kearns, Nora Pashayan, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
The Lancet. Psychiatry
|
August 23, 2015
Improved identification of people at risk of psychosis: is it value for money?
Ben Kearns
Pharmacoeconomics
|
October 5, 2013
Aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar I disorder in children and adolescents: a NICE single technology appraisal
Lesley Uttley, Ben Kearns, Shijie Ren, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 6, 2022
Optimizing the Design of a Repeated Fecal Immunochemical Test Bowel Cancer Screening Programme With a Limited Endoscopy Capacity From a Health Economic Perspective
Sophie Whyte, Chloe Thomas, Jim Chilcott, et al.
Pharmacoeconomics
|
November 26, 2019
How Uncertain is the Survival Extrapolation? A Study of the Impact of Different Parametric Survival Models on Extrapolated Uncertainty About Hazard Functions, Lifetime Mean Survival and Cost Effectiveness
Ben Kearns, John Stevens, Shijie Ren, et al.
Pharmacoeconomics
|
April 13, 2013
Cabazitaxel for the second-line treatment of metastatic hormone-refractory prostate cancer: a NICE single technology appraisal
Ben Kearns, Myfanwy Lloyd Jones, Matt Stevenson, et al.
BMC Medicine
|
February 5, 2017
Erratum to: Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation
Ben Kearns, Jim Chilcott, Sophie Whyte, et al.
BMC Research Notes
|
July 9, 2014
Predicting preference-based utility values using partial proportional odds models
Roberta Ara, Ben Kearns, Ben A vanHout, et al.
BMC Medicine
|
December 7, 2016
Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation
Ben Kearns, Jim Chilcott, Sophie Whyte, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
June 20, 2023
A Systematic Review and Statistical Analysis of Factors Influencing the Cost-Effectiveness of Transcatheter Aortic Valve Implantation for Symptomatic Severe Aortic Stenosis
Laura Heathcote, Tushar Srivastava, Archita Sarmah, et al.
British Journal of Cancer
|
October 17, 2023
The cost-effectiveness of risk-stratified breast cancer screening in the UK
Harry Hill, Ben Kearns, Nora Pashayan, et al.
Page
of 3